Biofeedback and the behavioral treatment of disorders of disregulation. by Schwartz, G. E.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 52 (1979), 581-596
Biofeedback and the Behavioral Treatment
of Disorders of Disregulation
GARY E. SCHWARTZ'
Yale University, New Haven, Connecticut
Received December 13, 1977
This paper reviews biofeedback research from the perspective of cybernetic/feedback theory and applies
the theory to the behavioral treatment of psychosomatic disorders. The concept of disregulation is used to
elucidate how environmental factors can modulate the central nervous system and effect homeostatic, self-
regulatory control of peripheral organs. When feedback from peripheral organs is disrupted, it is hypothe-
sized that disregulation occurs, leading to physiological instability and functional disease. Within this
framework, biofeedback provides a new feedback loop that can help individuals regain physiological self-
control. Basic research using biofeedback to enhance self-regulation of cardiovascular responses is reviewed.
The use of biofeedback in the behavioral treatment of disorders such as tension and migraine headache,
hypertension, and epilepsy are selectively reviewed and critically evaluated. The need to consider feedback
mechanisms in behavioral and biomedical approaches to treatment is highlighted. Predictions regarding the
potential inadvertent perpetuation of disregulation and disease through inappropriate biomedical interven-
tion is also considered.
Corrective information, termed negative feedback in cybernetic theory [1], is
fundamental to behavior that is self-regulatory. Unfortunately, the concept of
feedback is so obvious that it is often overlooked by health professionals and patients
alike. Everyone knows that they must have external visual feedback and internal
kinesthetic and proprioceptive feedback to tie a knot or to serve a tennis ball. In
neurophysiological terms, it can be said that the brain requires feedback ofwhat it is
doing and of its surroundings in order to appropriately regulate itself and its body
[2,3].
The product of twentieth century biomedical technology, biofeedback is a new
form of physiological information. With modern electronics it is now possible to
accurately monitor a variety of physiological processes and convert these signals into
novel forms of visual or auditory information. This information can be consciously
perceived and processed by the brain, and thereby self-regulated by the brain.
This development has stimulated extensive research on the voluntary control of
neural, visceral, and skeletal responses [4], and the application of biofeedback to the
behavioral treatment of psychophysiological disorders [5]. Although I emphasize a
neurophysiological interpretation of biofeedback and its application to the treatment
of psychosomatic or functional [6] disorders, this approach is recent in origin and
does not reflect the historical development of biofeedback [7].
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All rights of reproduction in any form reserved.The early research was derived primarily from learning theory, emphasizing
concepts and methods of instrumental [8] or operant [9] conditioning. However,
investigators who adopted a feedback perspective tended to stress the role of
information in self-regulation, whereas researchers who took a learning approach
tended to stress the role of incentives or motivation in the development and
maintenance of self-control [10-12]. As will be emphasized in this paper, information
and incentives are both important to the clinical application of biofeedback proce-
dures, and they can be understood in neurophysiological terms.
Yogis and meditators have long claimed unusual powers ofvoluntary control over
their physiology and consciousness, but until recently these claims were dismissed by
the scientific community. Since the previous scientific theories or paradigms could
not explain such claims, the claims were dismissed as being inaccurate or fraudulent
[13]. Not only did previous paradigms in medicine disallow the voluntary control of
visceral and glandular responses, but so did the prevailing learning paradigms in
psychology. However, stimulated by the development of biofeedback, coupled with
advances in neurophysiology, new paradigms have evolved which seek to explain and
extend these observations [e.g., 2,3]. In the process, this new information is revisihg
our theories of health and illness, and therefore the means by which we treat and
prevent disease.
Unfortunately, the initial fervor for biofeedback was so strong that it became
almost fanatical. At times the popular press was filled with uncritical enthusiasm for
almost any speculation about biofeedback as therapy. The electronics industry took
advantage of this interest and exploited biofeedback in both the medical and lay
markets. As a result, today there are at one extreme those who argue that biofeed-
back can enable humans to control any aspect of their biology at will; at the other
extreme, agrowing number now dismiss biofeedback as a useless gimmick. The thesis
of this article is that neither of these extremes is appropriate. Current research on
biofeedback not only expands our understanding of human self-regulation and its
applications to medicine, but also helps us recognize its limitations [14].
DISREGULATION: A PSYCHOBIOLOGICAL MODEL
OF PSYCHOSOMATIC DISORDERS
In order to appreciate thepotential and limitations of biofeedback in the treatment
ofpsychosomatic disorders, it is essential to view biofeedback within a biobehavioral
perspective. The following is a brief introduction to the psychobiology of psychoso-
matic disorders emphasizing the concepts of feedback [1] and disregulation [2,3].
The concept of feedback is central to an understanding of health and disease. As
originally posited by the French physiologist Claude Bernard and elaborated by
Walter Cannon in his classic volume, The Wisdom of the Body [15], there is a
biological necessity to maintain physiological variables within certain limits in order
to survive. This is accomplished by homeostasis, a process requiring an intact
nervoussystem. Homeostasis, therefore, is an internalnegative feedback mechanism,
devoted to the maintenance of the internal organs. In cybernetic terms [1], it is
negative in the sensethat thefeedback acts todampen overresponding in a corrective,
stabilizing manner. In this sense the brain can be viewed as acting like a biological
"health care" system [3].
It follows that ifthenegativefeedback circuit is altered or made ineffective, normal
self-regulation will not occur, and the system will become unstable (disordered). I
have called this instability disregulation [2,3] which is similar to Miller and Dwor-
kin's [16] concept of anti-homeostasis.
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In its simplest form, the model (see Fig. 1) is as follows: When the environment
(Stage 1) places demands on a person, the brain (Stage 2) performs the necessary
biobehavioral regulations to meet the specific demands. Depending upon the nature
of these environmental stresses, certain bodily systems (Stage 3) will be activated,
while others may simultaneously be inhibited. However, if this is continued to the
point of placing excessive strain on a given organ, the negative feedback loop (Stage
4) of the homeostatic mechanism will normally be accentuated, forcing the brain to
change its course of action. Sometimes the feedback can result in the subjective
experience of pain.
For example, if a person is overactive and eating on the run, the stomach mayfail
to function properly. As aresult, the stomach may generate sufficient feedback to the
brain to be experienced by the person as a stomach ache. From a health care point of
view, this corrective signal should serve the important negative feedback function of
causing the brain to change its regulation in specific ways, such as leading the person
to slow down and allow digestion to occur normally. Pain can serve a second
function in that it can "teach" the brain what it can and cannot do ifthe stomach is to
work properly. The adaptive brain is one that can learn through its mistakes. It
should learn to anticipate the needs of its organs for the sake ofthe organs' health.
However, the brain may fail to regulate itself effectively to meet the stomach's
needs. The reasons for this can be quite varied. As shown in Fig. 1, there are four











FIG. 1. Highly simplified block diagram depicting (1) environmental demands influencing via sensory inputs (not
shown), (2) the brain's regulation of its (3) peripheral organs, and (4) negative feedback from the periphery back to the
brain. Breakdowns in homeostasis and disregulation can be initiated at each ofthese stages. Biofeedback (Stage 5) is a
parallel feedback loop to Stage 4, detecting the activity of the peripheral organ (Stage 3) and converting it into
environmental information (Stage I) that can be used by the brain (Stage 2) to increase self-regulation (from [2]).
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Stage 1: Environmental Demands
The stimuli from the external environment may be so demanding that the brain
(Stage 2) isforcedto ignorethe negative feedback (Stage 4) generated bythe stomach
(Stage 3). This is the classic case of the person placed in unavoidable stress who must
continue to act in certain ways despite negative feedback to the contrary. Many
previous theories of psychosomatic disorders have emphasized this factor.
Stage 2: CNS Information Processing
The brain may be so programmed (initially through genetics and/or subsequently
through culture and learning) to respond inappropriately to the stimuli in the
external environment. This is what we in psychological or behavioral terms refer to as
personality or life style. Thus, although feedback from the abused organ may be
present, the person's brain may fail to react to it appropriately, as in denial or
repression.
Stage 3: Peripheral Organ
The organ may be hyper or hyporeactive to the neural or hormonal stimulation
coming from the brain. This is the literal translation of what has sometimes been
called the "weak organ" theory of psychosomatic disorders. It can explain why, in
response to the same environmental stress, people differ in the organ that ultimately
becomes dysfunctional. From this perspective, it is possible that the brain cannot
regulate itselfto compensate forthealtered feedback it is receivingfrom the organ. In
the case of a diseased organ, it may find itself no longer capable of modifying the
functioning of the organ.
Stage 4: Negative Feedback
Finally, the negative feedback derived from the organ may be inappropriate. In
other words, it is possible for the negative feedback itself to become less effective or
even inactivated. An extreme example ofthis condition can be seen in persons born
without the normal pain response system [17]. These individuals are constantly in
danger of severely injuring themselves, for they lack the protective mechanisms for
detecting and coping with injury.
Although the etiology of disregulation can occur at any of these four stages, the
general consequence of disregulation is the same in each case. By not responding
appropriately to negative feedback (Stage 4) the brain (Stage 2) fails to maintain
stable regulation of the organ in question (Stage 3) and disregulation (with its
accompanying instability) emerges.
Not only can disregulation occur at each of the four stages in the system, but it is
possible for problems to occursimultaneously at multiplestages. In the extreme case,
if a person was (1) exposed to demanding stimulation in his environment, requiring
continued adaptation (Stage 1), and (2) his brain processed the sensory information
and reacted inappropriately due to genetic and/or learning factors (Stage 2), and(3)
the peripheral organ itself reacted inappropriately due to genetic and/or matura-
tional factors (Stage 3), and(4) the feedback mechanism derived from this organ was
also ineffective (Stage 4), this combination would dramatically increase the likeli-
hood that such a person would develop a specific stress-linked disorder. Since the
brain and body are composed of multiple systems that must be coordinated in an
integrated fashion, it becomes necessary to examine each ofthe components and then
consider how they combine so as to produce the final outcome/disease.
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This holistic perspective to psychosomatic disorders illustrates how the functioning
of the system as a whole (Stages 2-4) requires the adaptive coordination of all of its
components in response to a variety of environmental demands (Stage 1). By
emphasizing the concept offeedback, the disregulation model provides a framework
for viewing biofeedback as the creation of a new feedback loop (Stage 5) to
potentially augment homeostasis/self-regulation [2]. By taking a neurophysiological,
multiprocess perspective, the disregulation model can help delineate the conditions
under which biofeedback will or will not be effective as a clinical tool.
BIOFEEDBACK AND PHYSIOLOGICAL
SELF-REGULATION: BAS1C RESEARCH
Hundreds of basic research studies have now been published, demonstrating
enhanced physiological control with feedback and reward. The list of responses
brought under self-control includes systolic and diastolic blood pressure, heart rate,
blood flow, sweat gland activity, skin temperature, body temperature, respiratory
functions, genital responses, stomach motility, skeletal muscle control (including
single motor units), and various changes in the electrical activity of the brain. Many
of these studies are reprinted in a set of Biofeedback and Self-Control volumes [e.g.,
18-23] and are critically evaluated elsewhere [4].
A useful example of basic biofeedback research concerns blood pressure self-
regulation in normotensive subjects. It is now well established that normal subjects
can learn to regulate their systolic and diastolic blood pressure depending upon the
nature of the feedback, instructions, and rewards used. If subjects are given simple
binary (tones or lights, on-off/yes-no) feedback for relative increases or decreases in
systolic pressure at each beat of the heart, are given minimal instructions about what
they are to do (they are not told what specific response they are to control, nor are
they told in what direction their physiology is to change), and rewards in theform of
slides (in these early studies, male subjects saw pictures from Playboy magazines),
subjects can learn in 25 one-minute trials to increase or decrease voluntarily their
systolic pressure without producing similar changes in heart rate[24,25]. Conversely,
if the feedback and reward is provided for increases or decreases in heart rate, and
minimal instructions are again used, subjects rapidly learn to increase or decrease
their heart rate without similarly changing their systolic pressure [26]. These data
illustrate how biofeedback procedures can enable subjects to learn to control specific
responses associated with the feedback in the absence of specific organ instructions.
ln more neurophysiological terms, if the brain is required to process the external
feedback without any "preconceived notions," it readily learns to regulate those
specific neural processes required to activate the periphery and thereby control the
feedback.
Subjects can learn to regulate two or more responses simultaneously if feedback
and reward is given for the desired pattern of responses. For example, if subjects are
given binary feedback and slide rewards only when their systolic blood pressure
and heart rate simultaneously increase (BPUPHRUP) or simultaneously decrease
(BPdOWl HRdOWn) subjects now learn to regulate both responses [27]. Interestingly,
teaching subjects to control patterns of responses uncovers biological linkages and
constraints between systems not readily observed when controlling the individual
functions alone [3,11,14]. For example, when subjects are taught to lower both their
systolic pressure and heart rate simultaneously, they tend to show more rapid
learning, produce somewhat larger changes, and experience more of the subjective
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concomitants of relaxation than when they are given feedback for either function
alone [27]. When subjects are given pattern biofeedback for making these responses
go in opposite directions (BPUPHRdown or BPdoWfn HRUP), regulation of the. two
responses is attenuated. These observations are important because they highlight the
concept of physiological patterning in both basic research and clinical treatment
[3,11,14] and emphasize natural physiological constraints that must limit the degree
of neural control possible.
In all of the above-mentioned studies, subjects were given minimal instructions
about the task. When subjects are specifically instructed to control their heart rate or
blood pressure, however, the subject may demonstrate physiological control even in
the absence of any feedback [28,29]. However, it is a mistake to conclude that
instructional control is identical to regulation gained through biofeedback! Whereas
single system biofeedback leads to learned specificity, instructions often lead to more
complex patterns of responses. Hence, the verbal instruction to control blood
pressure leads to control of heart rate as well, whereas single system biofeedback for
blood pressure with minimal instructions can lead to blood pressure control in the
absence of heart rate control. It follows that the precise nature of the biofeedback and
the specific instructions used both contribute to the finalpattern of responses that the
subject will learn to regulate. It should not be surprising to learn that instructions
differentially influence physiology. The average adult brain can draw on a variety of
neural strategies in its conscious repertoire to control the feedback. Depending upon
the specific nature of the instructions, the biocognitive strategies will vary, and
therefore so will the peripheral response patterns.
This issue is of more thanjust academicimportance. For example, in certain cases
ofhypertension the goal may be to lowerperipheral resistance in the absence of heart
rate changes, whereas for the treatment of angina pectoris the goal may be to lower
the pattern of blood pressure and heart rate since the product of these two functions
leads to reduced work ofthe heart and consequently reduced pain [30]. At the present
time, however, we can onlyspeculate as to what kinds of biofeedback procedures and
instructions are best combined to produce these two different cardiovascular results,
for there are as yet no controlled clinical studies on this issue.
CLINICAL APPLICATIONS OF BIOFEEDBACK: A CRITICAL OVERVIEW
At the present time there are over 100 published papers on clinical applications of
bijofeedback techniques. Many of these papers are based on collections of case
studies, and it is difficult to interpret them. Several critical reviews have been written
which cover a wide variety of clinical applications [e.g., 5,12,16,31,32], including
tension headache, asthma, bruxism, muscular rehabilitation, epilepsy, hypertension,
cardiac arrythmias, Raynaud's disease, migraine, sexual responses, pain, and anxiety.
Many of these reports represent only pilot studies and, while suggestive, all require
carefully controlled clinical trials to evaluate them.
The clearest evidence for theefficacy ofbiofeedback therapy grows out of research
on theregulation ofskeletal muscleactivity. This should not be surprising, since of all
the bodily systems the skeletal muscles are under the most voluntary control, and
feedback of their activity (both external and internal) are most extensive and
available to the conscious brain. A clinical example is tension headaches, where the
major symptom, pain, is often due to excessive and prolonged tension of the muscles
in theforehead and neck. Stoyva and Budzynski have demonstrated that biofeedback
for changes in frontalis muscle activity can enhance a patient's ability to voluntarily
decrease forehead tension, which, inturn, leads to reduced pain. In one experiment,
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they found that clinical improvement was significantly greater in the frontalis
biofeedback treatment group compared to two control groups, one given false
biofeedback, the other given no treatment at all [33].
There is little question that biofeedback can enhance the self-regulation of muscle
activity. In fact, it has been demonstrated that subjects can gain control ofindividual
motor units within a single muscle when provided with the appropriate biofeedback,
even though these changes are well below the level of normal awareness [34].
However, Stoyva and Budzynski are careful to point out that gaining control over
frontalis tension with biofeedback in the laboratory is but a prerequisite for clinical
improvement. Patients must also practice self-regulation in real life situations outside
the laboratory in order for the biofeedback training to have any long-term clinical
value. This observation is understandable within the disregulation model, sincethere
is no reason to expect that enhancing self-regulation via the addition of external
feedback will in and of itself compensate for headache disregulation, especiallyifthe
etiology and maintenance of the disorder involves excessive environmental stresses
(Stage 1) or maladaptive life styles (Stage 2). Stoyva and Budzynski are careful to tell
their patients that they should use the enhanced awareness of muscle tension in their
daily life as a signal for them to change their environment and/or their life style
(including coping style) in order to maintain low tension levels. If they do not,
disregulation will continue and their headaches will likely return.
There are numerous other applications of muscle tension biofeedback under
investigation, including applications to various neuromuscular disorders such as
hemiplegia due to stroke, reversible physiological blocks due to edema, and Bell's
palsy [see 32]. The extent of muscle retraining depends in large measure on the
precise nature of the etiology, including the extent ofcentral (Stage 2) and peripheral
(Stages 3 and 4) damage. It is likely that such workwill continue to progress, and that
feedback techniques may develop into a standard adjunctive treatment in physical
rehabilitation.
There are other more general muscle biofeedback applications of relevance to
psychosomatic medicine and psychiatry. Whatmore and Kohli [6] claim that the
training of whole body muscle relaxation can be used as a treatment for such skeletal,
autonomic, and affective disorders asfunctional backache and neck pain, hyperventi-
lation syndrome, hypertension, ulcers, anxiety, and depression. Like Jacobson [35]
before them, they argue that chronic muscletension in various parts ofthe body plays
an important role in the development and maintenance of disregulation disorders,
and through muscle biofeedback these functional disorders can be eliminated. Their
neurophysiological model of "dysponesis," including case studies involving pro-
longed muscle retraining collected over a 20-year period, is described in The
Physiopathology and Treatment ofFunctional Disorders[6]. Whiletheir approach is
promising, particularly in their consideration ofpossible neurophysiological mechan-
isms and their emphasis on multi-process treatment programs, it must be recognized
that their conclusions are based entirely on uncontrolled case reports. Carefully
designed outcome studies have yet to be carried out demonstrating that the use of
biofeedback training in the regulation of muscle tension has a central role in the
treatment of these disorders.
A second major area ofbiofeedback therapy involves feedback for electroencepha-
lographic (EEG) activity ofthe brain. The most well-documented studies are those by
Sterman and colleagues [36] in which biofeedback trainingfor EEG activity recorded
from the scalp over the sensory/motor cortex is used to reduce specific epileptic
seizures. Sterman claims that one particular sensory motor rhythm (SMR) between
58712 and 14 hz must be regulated by the patient in order for reduction of seizures to
occur. However, this conclusion may be premature, since other rhythms in this same
region such as sensory/motor alpha (8-13 hz) may reflect similar brain processes. In
any event, Sterman claims that when selected patients learn to inhibit sensory motor
processes, reductions in seizures can occur. What is not known is whether training in
general muscle relaxation (which by definition involves regulation of the sensory
motor cortex) is sufficient for obtaining clinical improvement.
Like biofeedback for peripheral skeletal motor responses, it should not be
surprising to learn that biofeedback for various EEG changes results in rapid self-
control. This is because surface EEG typically reflects complex neural processes
underlying normal voluntary control by the brain of its sensory, attentional,
cognitive, and skeletal processes [2]. However, the claim that training for EEG alpha
(without regard for cerebral localization) will lead to general relaxation and altered
states of consciousness [37] is now recognized as being too simplistic [3,14].
Furthermore, altered states of awareness can so readily be achieved through simple
cognitive, attentional, and somatic exercises already under a person's voluntary
control [e.g., 38,39] that biofeedback for EEG may be irrelevant to this goal.
Stoyva and Budzynski [40] point out, however, that for certain patients (e.g., those
with insomnia) a multi-stage training procedure may be needed-for inducing low
arousal, drowsiness, and sleep: (1) training in forearm muscle relaxation (which is
quite easy), followed by (2) training in frontalis muscle relaxation (which is more
difficult), followed by (3) training in EEG theta (4-7 hz) activity (which is quite
difficult). What becomes clear is that blanket statements for or against the use of
biofeedback techniques are premature and likely incorrect.
The last class of biofeedback applications involves feedback for visceral and
glandular responses regulated by the autonomic nervous system. One major area of
application under investigation involves the treatment of migraine headache. In an
uncontrolled clinical trial, Sargent and colleagues [41] have claimed that training
migraine patients simultaneously to increase warmth in the fingers and decrease
warmth in the forehead region using pattern temperature biofeedback leads to the
reduction of migraine headaches. They combined biofeedback with instructions to
imagine that one's hands were heavy and warm, based on a cognitive self-regulation
therapy called autogenic training [42]. The rationale for using "autogenic-feedback"
training was suggested to them by the experience of a research subject who, during
the spontaneous recovery from a migraine attack, demonstrated considerable
flushing in her hands with an accompanying10°F rise in two mintues. In subsequent
work with 19 patients with migraine headache, Sargent et al. reported improvement
in 63 percent.
Despite these encouraging findings, it is not known whether these same results
could have been obtained with autogenic phrases alone, or if comparable results
might have been observed through spontaneous remission and/or a "placebo" effect.
Again, the issue is not simply whether biofeedback can be used to regulate tempera-
ture. As recently reviewed by Taub [43], highly localized control ofskin temperature
can be trained with temperature biofeedback. What is not clear is whether tem-
perature biofeedback training is necessary and/or sufficient for the treatment of
migraine. Nor is it known whether biofeedback for other parameters such as blood
flow in the inflicted area will be more beneficial. In this regard, biofeedback for
temperature and blood flow are currently considered as a potential adjunctive
treatment for Raynaud's disease. Successful cases have been described [43-45], but
the interpretation of these cases is unclear.
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Biofeedback for disorders of cardiac rhythms such as tachycardias and preventri-
cular contractions (PVCs) has been investigated by Engel and colleagues [46]. There
is little question that certain patients can reduce the frequency of PVCs by regulating
heart rate. Interestingly, for some patients this is accomplished by decreasing
sympathetic tone; in other cases it is achieved by decreasing parasympathetic tone. It
appears that, depending upon the specific etiology of the arrhythmia, different
components of the neural innervation must be self-regulated to achieve clinical
improvement.
A major application of autonomic biofeedback involves feedback for blood
pressure in the regulation of essential hypertension. Based on our blood pressure
findings obtained in normotensive subjects [24-27], we studied seven patients with
essential hypertension [47]. After between 5 and 16 control sessions, patients were
given daily biofeedback sessions for lowering systolic pressure. Large decreases in
pressure were obtained in five ofthe patients, ranging from 16 to 34 mmHg after 12
to 34 training sessions. Using a more sophisticated subject design where patients were
taught to both decrease and increase pressure with systolic blood pressure biofeed-
back, Kristt and Engel [48] have replicated and extended these findings. In their
study, daily blood pressure readings were obtained outside of the laboratory with a
three-month follow up. These data suggest that blood pressure biofeedback can be
used to help hypertensive patients regulate their pressure. However, it is not known
whether blood pressure biofeedback is either necessary or sufficient for achieving
clinical improvement. For example, Jacobson[35] reported that large blood pressure
decreases could be obtained through general muscle relaxation, and Whatmore and
Kohli [6] have extended this observation using biofeedback for muscle tension.
The utility of biofeedback in visceral self-regulation appears to be especially well
documented in the training of rectosphincteric responses for the treatment of fecal
incontinence. Engel and colleagues [49] used pattern biofeedback for training
external sphincter contraction in synchrony with internal sphincter relaxation in six
patients with severe fecal incontinence. During follow-up periods ranging from 6
months to 5 years, four of the patients remained completely continent and the other
two were definitely improved. The technique was simple to apply and learning
occurred within four sessions or less. Engel and colleagues emphasize that not only
can sphincter activity be brought under voluntary control (a phenomenon long
recognized) but that this control can be reintroduced in patients with chronic fecal
incontinence, even when the incontinenceis secondary to organiclesions. Clearly, the
capacity for neural control must have been present in these patients for the
biofeedback to have been effective.
A final example concerns the possible use of intestinal biofeedback in the
treatment offunctional diarrhea. Furman [50] reports that subjects can rapidly learn
to reduce stomach and colon activity when given auditory biofeedback using a
simple, electronic stethoscope. Furman applied this procedure to five patients with
functional disorders of the lower gastrointestinal tract who manifested no organic
findings. Response to treatment-was uniformly positive. Furman claims that even
patients who had experienced a lifetime of functional diarrhea and who had been
virtually toilet bound are now enjoying normal bowel function. Although controlled
studies have yet to be carried out usingthistechnique, Furman's studyillustrates how
simple modes of feedback may be utilized by the patient and therapist as a team to
aid in regaining control over a functional disorder.
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DISREGULATION DISORDERS
It is clear that there are many potential applications of biofeedback in the
treatment of physiological disorders. It is also clear that the exacting work of
conducting controlled clinical studies to determine the validity and limitations of
biofeedback for specific disorders with particular patients isjust beginning. It will be
years before definite conclusions can be drawn. Issues of expectancy, placebo
responses, spontaneous remission, and others, must be considered [2,1-6,31] since
they apply to any behavioral or biological treatment in psychiatry and medicine.
However, biofeedback research is providing more than just a potential clinical
technique. It is providing a new research tool for understandingfunctional disorders,
and, as I have illustrated, it is stimulating new neurophysiological analyses of normal
and abnormal physiological self-regulation [2,3]. These analyses, in turn, serve to
illuminate both the potential and limitations of biofeedback as a self-regulation
therapy. They emphasize how biofeedback must be viewed as only one component of
multi-process approach to treatment if long-term clinical gains are to be obtained.
For example, one issue of historical relevance to the development of biofeedback
therapy concerns the so-called direct versus indirect approach [45,51]. The simple,
direct approach is to provide the patient withfeedback for a specific symptom for the
purpose of self-regulating the symptom. Once self-regulation is acquired, the hope is
that the symptom will remain under control and disappear. The indirect approach is
broader in scope; it argues that patients should learn to regulate as many as possible
of the underlying components or mediating processes contributing to the disorder,
including environmental and behavioral factors.
The indirect approach argues that biofeedback can be used to signal both the
therapist and the patient that the patient is currently thinking, feeling, or doing
specific things that are detrimental to his physical or emotional health. A well-known
example of this approach is the use of feedback in the treatment of obesity. In the
same way that a scale helps direct the therapist and his obese patient in learning how
to reduce food consumption and/or to increase exercise in order to reduce weight
(rather than the patient spending hours onthe scale attemptingto lower his weight by
thought processes alone), biofeedback for physiological disorders can be similarly
employed. By means of the immediate, augmented feedback (with its associated
increased bodily awareness) the patient can learn new ways ofcoping cognitively and
behaviorally with his environment (Stage 2 CNS information processing) and/or he
can learn to alter his environment (Stage 1) in such a way as to keep his physiological
processes (Stage 3) within safer limits. Inthis respect biofeedback is similar to current
psychotherapies, for they all provide corrective feedback [45] in the cybernetic sense
[1].
By recognizing that disregulation disorders can have multiple etiologies requiring a
multi-process treatment program, it becomes possible to determine more precisely
what combination offactors is contributing to the disorder in the individual patient,
and what combination or pattern of treatment approaches should be used in each
individual case [2,3]. For example, if it were found in a given hypertensive patient
that the high pressure tended to occur in anger-arousing situations, the therapist
could employ a variety of cognitive and behavioral approaches, including, for
instance, role playing, as a means ofteaching the person better ways of handling his
aggression. Or, if the patient had difficulty relaxing in situations of moderate stress,
the therapist could employ avariety ofcognitive and behavior relaxationprocedures,
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including muscle relaxation and meditation procedures, as a means of teaching the
person better ways of reducing excessive tension. As part of the treatment, however,
both the therapist and patient would profit from intermittent biofeedback (aug-
mented Stage 4) of blood pressure to ensure that the treatment regime was effective.
This use offeedback is similar to what the physician normally does when he monitors
the patient's pressure as a means of titrating drug effects. The difference here,
however, is the emphasis on the patient via the negative feedback (Stage 4) taking a
more active role in monitoring his physiological processes (Stage 3) and in self-
regulating his behavior (Stage 2) and environment (Stage 1).
There are numerous issues that need to be resolved, not the least of which is
economy. Is biofeedback too expensive to be considered on a large-scale basis,
especially if non-electronic relaxation procedures in and of themselves prove suffi-
cient to produce clinically significant long-term changes [39]? It seems probable that
certain patients with certain disorders will not require augmented biomedical
instrumentation to achieveimprovement, but at this point it is premature to conclude
(and unlikely to happen) that this will be the case for all patients. The disregulation
model helps us to appreciate the multiplicity of factors contributing to functional
disorders, and helps us place factors such as secondary gain and suggestion (Stage 1)
and peripheral organpathology (Stage 3 and/or 4) in a total treatment approach [2].
To the extent that severe pathology reduces the brain's abilityto regulate the diseased
organ via normal and humoral factors, the limitations of biofeedback and other
behavioral approaches can be estimated. Here timing of treatment may be very
important, for a disorder may have progressed beyond the stage of reversibility by
biofeedback. The themes of self-regulation (broadly defined) and biofeedback (in
particular) have provided one impetus for developing the field of "behavioral
medicine" [5]. It places more responsibility for both sickness and health in the hands
of the patient, and suggests new directions for preventive medicine by manipulating
Stages I and 2 before organic pathology in Stages 3 and 4 has a chance to develop.
However, when we view functional disorders in terms offour stages ofdisregula-
tion, and we recognize that a combination of stages can contribute to the final
disorder in the individual patient, it becomes clear why increasing external feedback
in and of itself may not be sufficient for long-term clinical gains, even with the use of
home trainers and ambulatory feedback devices. As mentioned earlier, the corrective
internal negative feedback loop (Stage 4) in normal homeostasis not only provides
information, but with few exceptions it also provides a strong incentive (i.e., pain),
for the brain (Stage 2) to regulate itself for the sake of the organ's health (Stage 3)
and, therefore, ultimately its own. For this reason, it is necessary for the therapist to
consider both the information value and incentive value of biofeedback in the total
treatment program. If the latter is lacking, the former will be short-lived.
In cases of extreme pain or embarrassment (such as in fecal incontinence), this
adaptive mechanism provides a strong incentiveforthe patient to seek treatment and
follow the regime. In these instances biofeedback may be particularly effective in
aiding the patient to gain self-control. Unfortunately, in other disorders, such as
essential hypertension, this adaptive mechanism is minimal or lacking. As a result,
not only does the patient lack the feedback that something is wrong, but when he
receives this feedback from his physician, he still lacks the built-in internal negative
feedback which would motivate him to recover.
A good illustration of this point comes from one of our hypertensive patients who,
during the feedback sessions, was successful in lowering his pressure [45]. Over the
five daily sessions of a typical week, he would lower his pressure by 20 mmHg and
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thus earn a total of over $35.00 for participating in the research. However, we
consistently noticed that after the weekend, he would enter the laboratory on
Monday with elevated pressures again. In interviews with the patient, the problem
became clear. After earning a sizeable amount of money, the patient would go to the
race track on the weekend, gamble, and invariably lose. The likelihood of teaching
this patient to "relax" while losing at the race track through simple laboratory blood
pressure feedback would seem slim, indicating that there is a need to change other
aspects of the patient's total life style, including developing some enduring incentive
system for sustaining his health.
The motivation issue helps clarify the distinction between learning a self-regulation
skill versus using that skill for the continued maintenance of one's health. The long-
term effectiveness of biofeedback, or, for that matter, any behavioral or biological
treatment program involving self-control (e.g., taking drugs), ultimately depends on
the patient's motivation and ability to continue using the self-regulation skill. This
distinction is an important one, for it helps us recognize the difference between
developing behavioral procedures for helpingpatients to help themselves, as opposed
to developing educational and social programs forleading patients to make effective,
long-term use of the new behavioral technology. This writer is of the strong opinion
that we are closer to solving the former than the latter. The ultimate clinical value of
biofeedback and other self-regulation procedures for the treatment of disregulation
disorders will hinge on our success in solving both of them.
MEDICINE AND THE INADVERTENT
PERPETUATION OF DISREGULATION
One novel, and somewhat disturbingimplication ofthedisregulation model is that,
due to incomplete diagnosis and treatment of disorders involving disregulation, the
traditional biomedical model inadvertently leads to the enhancement of disregula-
tion. This applies not only to bodily disease but to human behavior more broadly
[2,3].
As described previously, disregulation can be initiated and perpetuated at four
basic stages. Often, the disregulation is initiated by stimulus demands from the
outside environment (Stage 1), coupled with the brain's reaction to them(Stage 2). If
the brain is exposed to (or exposes itself to) environmental conditions which
ultimately cause an organ system (Stage 3) to break down and develop a functional
disorder, the appropriate internal negative feedback loops can be activated (Stage4).
This information can serve a vital negative feedback function, since it can direct the
brain (Stage 2) to take corrective action if the organ is to survive. Even ifthe brain is
busy attending to other stimuli in the outside environment, and thus fails to recognize
the breakdown of a given organ, at some point the organ (if its negative feedback
loop is intact) will generate sufficient negative feedback to redirect the brain's
attention. Any person who has experienced a strong stomach ache caused by
overeating, eating under the wrong circumstances, or eating the wrong food, knows
the power that negative feedback can have in commanding our attention and our
subsequent behavior.
What "should" the brain's response be to this internal stimulation? From a
negative feedback, cybernetic perspective, it becomes clear that the brain should
either change the external environmental demands (Stage 1) or its behavior (Stage 2)
to maintain the health of the organ (Stage 3). Consequently, the intrinsic pain of the
disturbed stomach (Stage 4) can help to keep our behavior in check by forcing us to
stop eating, or to stop running while we are eating, or to not eat the dangerous food
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again. It is only in this context that the pain is allowed to act as a negative feedback
stimulus.
However, for many sociological reasons, man is not content to follow his initial
biological heritage. He either feels no longer competent to change his environment or
behavior, or simply does not want to. However, due to his highly developed brain
and the resulting development of culture, he is no longer constrained to deal with the
negative feedback by responding to organ dysfunction in terms of the body's normal
structure. Instead, the typical patient would rather change his body structure (Stages
3 or 4) than change his lifestyle (Stage 2) or his environment (Stage 1), the two factors
which together augment or cause the bodily dysfunction in the first place. Simply
stated, man may choose instead to modify Stage 3 and/or 4 by certain extrinsic
biological interventions. As would be predicted from the disregulation model, by
artificially removing the negative feedback mechanisms, the brain becomes freed to
continue behaving in maladaptive ways that could ultimately be deleterious to its
survival. Lacking the stabilizing impact of the negative feedback regulation, the brain
(and therefore its expression as behavior) goes more and more out of control [2].
Consider the stomach ache once again. At no time in human history has human
culture so reinforced the practice of taking drugs to eliminate stomach aches caused
by the brain's disregulation. The antacid commercials of the 1970s exemplify this
value system. One commercial showed an obese man stuffing himself with apple pies
or spaghetti. When he got a functional stomach ache, the conclusion was not: "The
stomach and the rest of the body were not meant to eat like that-your stomach ache
represents the necessary biological feedback mechanism that will help keep you from
further abusing your body." Instead, what we heard was "Eat, eat-and if you get a
stomach ache, don't change your external environment or behavior-rather, elimi-
nate the internal discomfort artificially by taking a pill instead." Or the commercial
depicted a family shopping at Christmas time, surrounded by crowds, struggling to
hold the packages, rushing from counter to counter, continually inhibiting aggression
caused by being bumped or offended in other ways. And, in the process, one of the
members of the family got a stomach ache. The conclusion to this scenario based on
the disregulation model "The stomach and the rest ofthe body were not meant to live
like that-your stomach ache represents the necessary biological feedback mechan-
ism that will help you from further abusing your body" was not the message of the
commercial. Rather, what we were told was "Shop, shop-and if you get a stomach
ache, don't change your external environment or behavior-rather, eliminate the
discomfort artificially by taking a pill instead."
Simple antacids are mild drugs, and do not always work. When this happens,
medicine comes to the rescue with stronger medication to quell the pain. Then when
the organ becomes sufficiently abused so that an ulcer develops and internal bleeding
occurs, does the person now listen to his stomach and radically change his external
environment and behavior? Often not; what he does instead is to go to his surgeon
and have the stomach repaired. Medicine, by dint of its continued technological
success and ingenuity, is developing new and finer means of bypassing these normal
adaptive feedback mechanisms. Thus, in extreme cases a patient can have a
vagotomy, thereby eliminating the brain's capability to regulate the stomach directly.
And if the trend in modern medicine continues, man can look forward to the day
when he can simply go to his local surgeon and be fitted with a new, artificial "super"
stomach that will not only be stronger, but will produce no pain.
In this situation, we would have a brain that was no longer constrained by the
needs of its natural stomach. According to the disregulation model, such a brain
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would be freed to continue and even expand upon the inappropriate disregulation
that was the initial cause of the problem (overeating, running around too much, and
the like).
The stomach is only one organ, of course. However, modern medicine is pursuing
the same strategy for many of the systems ofthe body. Modern culture is continually
reinforcing the idea that if the brain and its body cannot cope with its external
environment, then the body and brain will simply have to alter itself medically to
adjust to the increasingly maladaptive demands ofthe environment. According to the
disregulation model, this prospect, if carried to an extreme, could have serious
consequences for the structure and survival of the human species.
One should not come to the erroneous conclusion that biomedical intervention is
always disregulatory, and, therefore, always has negative side effects in terms of
disrupting natural self-regulation. The disregulation model can help us determine
under what specific conditions, for what disorders, it is appropriate, not only in the
short run but more importantly in the long run, to use pharmacologic and/or surgical
interventions. The disregulation model helps us explain why we should not come to
the simplistic conclusion that the direct correction of Stages 3 and 4 of disregulation
by medical means should be the sole approach to treatment. Clearly, the environ-
ment (Stage 1) and our behavior (Stage 2) must be regulated in order to prevent
disease. Responsible health care providers know that treating symptoms rather than
causes is, in the long run, not effective. In the context of the present paper, treating
symptoms rather than causes is, in the long run, inherently disregulatory. The
feedback (Stage 4) ofillness should serve as a corrective "negativefeedback" stimulus
that leads us to make, whenever possible, needed changes in the environment and in
our behavior. It may be necessary for health professionals, government officials, and
the public alike to accept and respect in Cannon's [15] term the wisdom (and
limitations) of the body (Stages 3 and 4) as it was originally designed, even though
this may require more active regulation of the environment (Stage 1) by the brain
(Stage 2) to keep the health and behavior of the human species intact. Biofeedback
(Stage 5) can play a role in helping us to reach this goal.
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